SCHEMBL361870

SCHEMBL361870

CCC(C)(O)C(=O)O.CCOC(=O)C(C)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TET2 Q6N021 1/20 0.37
MMP8 P22894 1/20 0.34
METAP2 P50579 3/20 0.33
ALDH1A1 P00352 2/20 0.33
METAP1 P53582 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PIN1 Q13526 1/20 0.32
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
TSHR P16473 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30924919 1.00 TET2 (0.37) TET2MMP8METAP2ALDH1A1METAP1
SCHEMBL30112250 1.00 TET2 (0.37) TET2MMP8METAP2ALDH1A1METAP1
SCHEMBL30455727 0.86 ALDH1A1 (0.46) MMP8METAP2ALDH1A1METAP1SMN1; SMN2
Lactic Acid SCHEMBL367662 0.82 TP53 (0.50) TET2ALDH1A1CYP2C19TSHRTP53
Isopropyl Alcohol SCHEMBL1972399 0.82 TET2 (0.46) TET2ALDH1A1CYP1A2CYP2C19TSHR
Hydrogen Peroxide SCHEMBL5367632 0.82 ALDH1A1 (0.48) MMP8ALDH1A1LMNAHSD17B10PIN1
Bicarbonate SCHEMBL28391088 0.80 ALDH1A1 (0.46) MMP8ALDH1A1LMNAHSD17B10PIN1
SCHEMBL344175 0.79
SCHEMBL471892 0.79 ALDH1A1 (0.50) MMP8METAP2ALDH1A1METAP1LMNA
SCHEMBL22598 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118899539-A Preparation method of lithium ion battery high-entropy ester electrolyte suitable for ultralow-temperature working condition 中国科学院大连化学物理研究所 2024-11-05 CN claimed
US-20240269229-A1 NOVEL LIPOPEPTIDE FORMULATION ADVAPHARM GMBH (DE) 2024-08-15 US claimed
CN-118215469-A Novel lipopeptide formulations ADVAPHARM股份有限公司 2024-06-18 CN claimed
CN-118131583-A Diluent composition for removing coloring photosensitive resin 德山新勒克斯有限公司 2024-06-04 CN claimed
CN-110824837-B Photosensitive resin composition and patterning method using the same 新应材股份有限公司 2023-04-28 CN claimed
WO-2023041588-A1 NOVEL LIPOPEPTIDE FORMULATION ADVAPHARM GMBH (DE) 2023-03-23 WO claimed
EP-4746652-A1 PEROVSKITE TANDEM SOLAR CELL Hanwha Solutions Corporation (KR) 2026-05-20 EP disclosed
CN-121586260-A Semiconductor structure and manufacturing method thereof 南亚科技股份有限公司 2026-02-27 CN disclosed
WO-2025132660-A1 METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION L'OREAL (FR) 2025-06-26 WO disclosed
CN-114326301-B Polyimide positive photoresist composition and use thereof 台湾永光化学工业股份有限公司 2025-05-16 CN disclosed
CN-119937243-A Chemically amplified positive photosensitive resin composition, cured film, and element having cured film 奇美实业股份有限公司 2025-05-06 CN disclosed
CN-119923600-A Chemically amplified positive resist composition for improving pattern profile and enhancing adhesion YC化学制品株式会社 2025-05-02 CN disclosed
CN-119902413-A Photosensitive coloring resin composition, color filter, manufacturing method thereof and liquid crystal display device 奇美实业股份有限公司 2025-04-29 CN disclosed
US-20130306970-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND USES THEREOF CHI MEI CORPORATION (TW) 2013-11-21 US disclosed
US-20130164461-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND USES THEREOF CHI MEI CORPORATION (TW) 2013-06-27 US disclosed
US-20120016072-A1 HARDENER FOR SILICONE RUBBER MATERIALS NITRO-CHEME ASCHAU GmbH (DE) 2012-01-19 US disclosed
US-8097402-B2 Using electric-field directed post-exposure bake for double-patterning (D-P) TOKYO ELECTRON LIMITED (JP) 2012-01-17 US disclosed
US-20080077352-A1 METHODS AND APPARATUS FOR USING AN OPTICALLY TUNABLE SOFT MASK PROFILE LIBRARY TOKYO ELECTRON LIMITED (JP) 2008-03-27 US disclosed
US-6733949-B2 ACID AND ALKALI ETCHING RESISTANT PROTECTIVE LAYER; IMAGE FORMATION OF MICROELECTRONIC DEVICE CLARIANT FINANCE (BVI) LIMITED (VG) 2004-05-11 US disclosed
US-5977288-A Fractionated novolak resin and photoresist composition therefrom CLARIANT FINANCE (BVI) LIMITED (VG) 1999-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016072-A1 HARDENER FOR SILICONE RUBBER MATERIALS HACD2, HACD3, ITGA2 TET2 4238/4885MMP8 2464/4885METAP2 4172/4885
US-20240269229-A1 NOVEL LIPOPEPTIDE FORMULATION LPXN, NGLY1, VIP TET2 4365/4885MMP8 979/4885METAP2 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.